Aurobindo Upbeat On Outlook, Transfers Biologics Biz

Seeks FDA Desk Reviews For Three Units

Business growth
Aurobindo Looks For Growth As It Carves Out Biologics Business • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip